WHO Global Patient Safety Challenge - Medication without harm
In March 2017, the World Health Organization (WHO) launched the third Global Patient Safety Challenge (Challenge) with the theme of medication without harm.
The goal of the Challenge is to gain worldwide commitment and action to reduce severe, avoidable medication-related harm by 50% in the next five years. The Australian Government made a commitment to participate in the Challenge, and the Commission is tasked with developing a national response.
The three focus areas of the Challenge are high-risk situations (high-risk medicines), polypharmacy and transitions of care. The high-risk medicines are anti-psychotics, insulin, opioids, heparin and anti-coagulants. More information on the focus areas can be found in the booklet from the WHO, Medication without harm 2017. To download the document visit: https://www.who.int/patientsafety/medication-safety/en/
In Australia, the goal is to reduce medication errors, adverse drug events and medication-related hospital admissions by 50% by 2025. The Commission is seeking input from stakeholders with programs that address high-risk medicines, polypharmacy, and transitions of care.
Consultation is now closed
The Commission is currently developing a response to the Challenge discussion paper. Public consultation on this response closed Friday 5 July 2019.
The consultation paper that was developed for this consultation is available below.